Three physician-scientists, including a top San Diego-based Alzheimer’s researcher, will get up to $70 million to accelerate clinical trials to find new treatments, under a grant from the National Institutes of Health.
Dr. Paul Aisen, of the University of Southern California but based in San Diego, leads the new Alzheimer’s Clinical Trial Consortium along with two peers. They are Dr. Ronald Petersen from Mayo Clinic in Minnesota, and Dr. Reisa Sperling from Brigham and Women’s Hospital in Massachusetts.
The consortium will “implement more efficient methods to recruit participants for clinical trials,” USC said in a statement announcing the grant.
Funds are to be given over five years. They will pay for support services, allowing researchers to design better clinical trials, and manage the great amount of data, and recruit participants from varied ethnicities.
Click here to read the full story by Bradley J. Fikes, San Diego Union Tribune.